CALM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.514200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.522200E-01
Normal-vs-Stage2
9.461800E-01
Normal-vs-Stage3
8.023600E-01
Normal-vs-Stage4
3.468400E-01
Stage1-vs-Stage2
4.367400E-01
Stage1-vs-Stage3
8.992600E-01
Stage1-vs-Stage4
8.975600E-02
Stage2-vs-Stage3
6.627000E-01
Stage2-vs-Stage4
2.052000E-01
Stage3-vs-Stage4
3.895000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.631600E-01
Normal-vs-AfricanAmerican
7.421400E-01
Normal-vs-Asian
5.212600E-01
Caucasian-vs-AfricanAmerican
6.889000E-01
Caucasian-vs-Asian
4.028400E-01
AfricanAmerican-vs-Asian
8.178000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.763200E-01
Normal-vs-Female
9.124400E-01
Male-vs-Female
7.790000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.264200E-01
Normal-vs-Age(41-60Yrs)
6.793600E-01
Normal-vs-Age(61-80Yrs)
7.488000E-01
Normal-vs-Age(81-100Yrs)
7.939200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.669800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.919200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.651600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.174130E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.493400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.576180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.402000E-01
Normal-vs-Daily Drinker
8.426600E-01
Normal-vs-Weekly Drinker
4.066600E-01
Normal-vs-Occasional Drinker
5.767400E-01
Normal-vs-Social Drinker
8.340000E-01
Non Drinker-vs-Daily Drinker
7.990800E-01
Non Drinker-vs-Weekly Drinker
3.270200E-01
Non Drinker-vs-Occasional Drinker
2.399000E-01
Non Drinker-vs-Social Drinker
8.391200E-01
Daily Drinker-vs-Weekly Drinker
4.623000E-01
Daily Drinker-vs-Occasional Drinker
1.715610E-01
Daily Drinker-vs-Social Drinker
9.738200E-01
Weekly Drinker-vs-Occasional Drinker
3.072200E-02
Weekly Drinker-vs-Social Drinker
4.133800E-01
Occasional Drinker-vs-Social Drinker
1.868410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.396610E-01
Normal-vs-Grade 2
6.735500E-03
Normal-vs-Grade 3
1.452130E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.668160E-02
Grade 1-vs-Grade 3
2.234000E-02
Grade 1-vs-Grade 4
1.396610E-01
Grade 2-vs-Grade 3
5.749800E-01
Grade 2-vs-Grade 4
6.735500E-03
Grade 3-vs-Grade 4
1.452130E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.632000E-01
Normal-vs-NonDiabetic
9.624400E-01
Diabetic-vs-NonDiabetic
1.326030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.825000E-01
Normal-vs-NoPancreatitis
9.618000E-01
Pancreatitis-vs-NoPancreatitis
9.042600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.035800E-01
Normal-vs-N1
9.468200E-01
N0-vs-N1
5.226200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.928400E-01
Normal-vs-TP53-NonMutant
4.844000E-01
TP53-Mutant-vs-TP53-NonMutant
3.41469999998179E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
